Avalanche Australia Pty Ltd

Status: Registered
Australian Company Number: 155723738
Australian Business Number: 49155723738
Registration date: 2012/02/15
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Avalanche Australia Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2012-02-15 and was issued with the 155723738 ACN. Its Australian Business Number is 49155723738. Since 2012-02-15, the company is headquartered in VIC, post code 3006. Avalanche Australia Pty Ltd was registered for the GST on 2012-04-01. The above data comes from the ABN database which was updated on 2013-02-19.


Details for ABN 49155723738

Type: Australian Private Company

ABN Status

Status From To
Active 2012/02/15 current

Main Name

Name From To
Avalanche Australia Pty Ltd 2012/02/15 current

Main Location

Location From To
VIC 3006 2012/02/15 current

Goods & Services Tax (GST)

Status From To
Registered 2012/04/01 current


Company Patents

Patent Application Number: 2013263159

General information:

Application date: 2014/12/04
Patent status: Filed

The specification prior to acceptance and where the application has not lapsed

Patent type: NPE
Primary IPC mark: A61K 35/76
WIPO Application Number: WO2013/173129
Original WIPO Application Number: WO13/173129
PCT Application Number: PCT/US2013/040011
Original PCT Application Number: PCT/US13/40011

International Patent Classification:

IPC Mark: C12N 15/86
Version date of the IPC Classification record: 2006/01/01
Section code: C - chemistrymetallurgy
Class code: 12 - biochemistry; beer; spirits; wine; vinegar; microbiology; enzymology; mutation or genetic engineering
Subclass code: N - micro-organisms or enzymes; compositions thereof (biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, micro-organisms or animal material a01n0063000000; medicinal preparations a61k; fertilisers c05f); propagating, preserving, or maintaining micro-organisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
Main group code: 15 - mutation or genetic engineering; dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; use of hosts therefor (mutants or genetically engineered micro-organisms c12n0001000000, c12n0005000000, c12n0007000000; new plants a01h; plant reproduction by tissue culture techniques a01h0004000000; new animals a01k0067000000; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy a61k0048000000; peptides in general c07k)
Subgroup code: 86 - viral vectors
Mark type: Later (ie Secondary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: 2014/01/30
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Expiry date: 2033/05/07
Earliest priority date: 2012/05/15
WIPO publication date: 2013/11/21
Effective patent date: 2013/05/07
Patent in force to: 2017/05/07

Find company

VIC 3006 Location

2017 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2017 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2017, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.